27776263|t|Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly.
27776263|a|The pathway leading from amyloid-beta deposition to cognitive impairment is believed to be a cornerstone of the pathogenesis of Alzheimer's disease (AD). However, what drives amyloid buildup in sporadic nongenetic cases of AD is still unknown. AD brains feature an inflammatory reaction around amyloid plaques, and a specific subset of the gut microbiota (GMB) may promote brain inflammation. We investigated the possible role of the GMB in AD pathogenesis by studying the association of brain amyloidosis with (1) GMB taxa with pro- and anti-inflammatory activity; and (2) peripheral inflammation in cognitively impaired patients. We measured the stool abundance of selected bacterial GMB taxa (Escherichia/Shigella, Pseudomonas aeruginosa, Eubacterium rectale, Eubacterium hallii, Faecalibacterium prausnitzii, and Bacteroides fragilis) and the blood expression levels of cytokines (pro-inflammatory cytokines: CXCL2, CXCL10, interleukin [IL]-1beta, IL-6, IL-18, IL-8, inflammasome complex (NLRP3), tumor necrosis factor-alpha [TNF-alpha]; anti-inflammatory cytokines: IL-4, IL-10, IL-13) in cognitively impaired patients with (n = 40, Amy+) and with no brain amyloidosis (n = 33, Amy-) and also in a group of controls (n = 10, no brain amyloidosis and no cognitive impairment). Amy+ patients showed higher levels of pro-inflammatory cytokines (IL-6, CXCL2, NLRP3, and IL-1beta) compared with both controls and with Amy- patients. A reduction of the anti-inflammatory cytokine IL-10 was observed in Amy+ versus Amy-. Amy+ showed lower abundance of E. rectale and higher abundance of Escherichia/Shigella compared with both healthy controls (fold change, FC = -9.6, p < 0.001 and FC = +12.8, p < 0.001, respectively) and to Amy- (FC = -7.7, p < 0.001 and FC = +7.4, p = 0.003). A positive correlation was observed between pro-inflammatory cytokines IL-1beta, NLRP3, and CXCL2 with abundance of the inflammatory bacteria taxon Escherichia/Shigella (rho = 0.60, p < 0.001; rho = 0.57, p < 0.001; and rho = 0.30, p = 0.007, respectively) and a negative correlation with the anti-inflammatory E. rectale (rho = -0.48, p < 0.001; rho = -0.25, p = 0.024; rho = -0.49, p < 0.001). Our data indicate that an increase in the abundance of a pro-inflammatory GMB taxon, Escherichia/Shigella, and a reduction in the abundance of an anti-inflammatory taxon, E. rectale, are possibly associated with a peripheral inflammatory state in patients with cognitive impairment and brain amyloidosis. A possible causal relation between GMB-related inflammation and amyloidosis deserves further investigation.
27776263	15	32	brain amyloidosis	Disease	MESH:D000686
27776263	42	54	inflammatory	Disease	MESH:D007249
27776263	89	101	inflammation	Disease	MESH:D007249
27776263	113	133	cognitively impaired	Disease	MESH:D003072
27776263	168	180	amyloid-beta	Gene	351
27776263	195	215	cognitive impairment	Disease	MESH:D003072
27776263	271	290	Alzheimer's disease	Disease	MESH:D000544
27776263	292	294	AD	Disease	MESH:D000544
27776263	318	325	amyloid	Disease	MESH:C000718787
27776263	366	368	AD	Disease	MESH:D000544
27776263	387	389	AD	Disease	MESH:D000544
27776263	408	420	inflammatory	Disease	MESH:D007249
27776263	437	452	amyloid plaques	Disease	MESH:D058225
27776263	522	534	inflammation	Disease	MESH:D007249
27776263	584	586	AD	Disease	MESH:D000544
27776263	631	648	brain amyloidosis	Disease	MESH:D000686
27776263	686	698	inflammatory	Disease	MESH:D007249
27776263	728	740	inflammation	Disease	MESH:D007249
27776263	744	764	cognitively impaired	Disease	MESH:D003072
27776263	765	773	patients	Species	9606
27776263	839	859	Escherichia/Shigella	Species	
27776263	861	883	Pseudomonas aeruginosa	Species	287
27776263	885	904	Eubacterium rectale	Species	39491
27776263	906	924	Eubacterium hallii	Species	39488
27776263	926	954	Faecalibacterium prausnitzii	Species	853
27776263	960	980	Bacteroides fragilis	Species	817
27776263	1032	1044	inflammatory	Disease	MESH:D007249
27776263	1056	1061	CXCL2	Gene	2920
27776263	1063	1069	CXCL10	Gene	3627
27776263	1095	1099	IL-6	Gene	3569
27776263	1101	1106	IL-18	Gene	3606
27776263	1108	1112	IL-8	Gene	3576
27776263	1136	1141	NLRP3	Gene	114548
27776263	1144	1171	tumor necrosis factor-alpha	Gene	7124
27776263	1173	1182	TNF-alpha	Gene	7124
27776263	1190	1202	inflammatory	Disease	MESH:D007249
27776263	1214	1218	IL-4	Gene	3565
27776263	1220	1225	IL-10	Gene	3586
27776263	1227	1232	IL-13	Gene	3596
27776263	1237	1257	cognitively impaired	Disease	MESH:D003072
27776263	1258	1266	patients	Species	9606
27776263	1281	1284	Amy	Chemical	-
27776263	1299	1316	brain amyloidosis	Disease	MESH:D000686
27776263	1326	1329	Amy	Chemical	-
27776263	1376	1393	brain amyloidosis	Disease	MESH:D000686
27776263	1401	1421	cognitive impairment	Disease	MESH:D003072
27776263	1424	1427	Amy	Chemical	-
27776263	1429	1437	patients	Species	9606
27776263	1466	1478	inflammatory	Disease	MESH:D007249
27776263	1490	1494	IL-6	Gene	3569
27776263	1496	1501	CXCL2	Gene	2920
27776263	1503	1508	NLRP3	Gene	114548
27776263	1514	1522	IL-1beta	Gene	3553
27776263	1561	1564	Amy	Chemical	-
27776263	1566	1574	patients	Species	9606
27776263	1600	1612	inflammatory	Disease	MESH:D007249
27776263	1622	1627	IL-10	Gene	3586
27776263	1644	1647	Amy	Chemical	-
27776263	1656	1659	Amy	Chemical	-
27776263	1662	1665	Amy	Chemical	-
27776263	1693	1703	E. rectale	Species	39491
27776263	1728	1748	Escherichia/Shigella	Species	
27776263	1868	1871	Amy	Chemical	-
27776263	1970	1982	inflammatory	Disease	MESH:D007249
27776263	1993	2001	IL-1beta	Gene	3553
27776263	2003	2008	NLRP3	Gene	114548
27776263	2014	2019	CXCL2	Gene	2920
27776263	2042	2054	inflammatory	Disease	MESH:D007249
27776263	2070	2090	Escherichia/Shigella	Species	
27776263	2220	2232	inflammatory	Disease	MESH:D007249
27776263	2233	2243	E. rectale	Species	39491
27776263	2379	2391	inflammatory	Disease	MESH:D007249
27776263	2403	2423	Escherichia/Shigella	Species	
27776263	2469	2481	inflammatory	Disease	MESH:D007249
27776263	2489	2499	E. rectale	Species	39491
27776263	2543	2555	inflammatory	Disease	MESH:D007249
27776263	2565	2573	patients	Species	9606
27776263	2579	2599	cognitive impairment	Disease	MESH:D003072
27776263	2604	2621	brain amyloidosis	Disease	MESH:D000686
27776263	2670	2682	inflammation	Disease	MESH:D007249
27776263	2687	2698	amyloidosis	Disease	MESH:D000686
27776263	Association	MESH:D000544	351
27776263	Association	MESH:D007249	3553
27776263	Association	MESH:D003072	351

